Exosomes — nano-sized extracellular vesicles involved in intercellular signalling — are gaining attention as potential therapeutic tools in regenerative medicine, oncology, neurology, and dermatology. Derived from stem cells and other cell types, they carry proteins, lipids, and nucleic acids that may modulate inflammation, promote tissue repair, and influence immune responses. Preclinical studies suggest promising roles in wound healing, neurodegeneration, cardiac repair, and even drug delivery platforms.
Early-phase clinical research is exploring exosome-based therapies in conditions such as osteoarthritis, chronic wounds, and inflammatory disorders. Their theoretical advantages — lower immunogenicity compared to cell therapy, easier storage, and potential for targeted delivery — make them attractive candidates in translational medicine. However, most current data remain small-scale,…
